These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31742358)
1. Regulatory oversight, causal inference, and safe and effective health care machine learning. Stern AD; Price WN Biostatistics; 2020 Apr; 21(2):363-367. PubMed ID: 31742358 [TBL] [Abstract][Full Text] [Related]
2. Addressing health disparities in the Food and Drug Administration's artificial intelligence and machine learning regulatory framework. Ferryman K J Am Med Inform Assoc; 2020 Dec; 27(12):2016-2019. PubMed ID: 32951036 [TBL] [Abstract][Full Text] [Related]
4. Continual learning in medical devices: FDA's action plan and beyond. Vokinger KN; Feuerriegel S; Kesselheim AS Lancet Digit Health; 2021 Jun; 3(6):e337-e338. PubMed ID: 33933404 [No Abstract] [Full Text] [Related]
5. Causal inference and machine learning in endocrine epidemiology. Inoue K Endocr J; 2024 Oct; 71(10):945-953. PubMed ID: 38972718 [TBL] [Abstract][Full Text] [Related]
6. Diabetes Technology Society Report on the FDA Digital Health Software Precertification Program Meeting. King F; Klonoff DC; Ahn D; Adi S; Berg EG; Bian J; Chen K; Drincic A; Heyl M; Magee M; Mulvaney S; Pavlovic Y; Prahalad P; Ryan M; Sabharwal A; Shah S; Spanakis E; Thompson BM; Thompson M; Wang J J Diabetes Sci Technol; 2019 Jan; 13(1):128-139. PubMed ID: 30394807 [TBL] [Abstract][Full Text] [Related]
7. Food and Drug Administration regulation of diabetes-related mHealth technologies. Brooke MJ; Thompson BM J Diabetes Sci Technol; 2013 Mar; 7(2):296-301. PubMed ID: 23566984 [TBL] [Abstract][Full Text] [Related]
8. Infrastructure for a learning health care system: CaBIG. Buetow KH; Niederhuber J Health Aff (Millwood); 2009; 28(3):923-4; author reply 924-5. PubMed ID: 19414908 [No Abstract] [Full Text] [Related]
9. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health. Ronquillo JG; Zuckerman DM Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231 [TBL] [Abstract][Full Text] [Related]
10. Reflection on modern methods: when worlds collide-prediction, machine learning and causal inference. Blakely T; Lynch J; Simons K; Bentley R; Rose S Int J Epidemiol; 2021 Jan; 49(6):2058-2064. PubMed ID: 31298274 [TBL] [Abstract][Full Text] [Related]
11. FDA regulation of medical software. Fried BM; Zuckerman JM J Health Law; 2000; 33(1):129-40. PubMed ID: 10788227 [TBL] [Abstract][Full Text] [Related]
12. U.S. Food and Drug Administration Precertification Pilot Program for Digital Health Software: Weighing the Benefits and Risks. Lee TT; Kesselheim AS Ann Intern Med; 2018 May; 168(10):730-732. PubMed ID: 29632953 [TBL] [Abstract][Full Text] [Related]
13. Machine Learning in Causal Inference: Application in Pharmacovigilance. Zhao Y; Yu Y; Wang H; Li Y; Deng Y; Jiang G; Luo Y Drug Saf; 2022 May; 45(5):459-476. PubMed ID: 35579811 [TBL] [Abstract][Full Text] [Related]
14. M-health: the union of technology and healthcare regulations. Silberman MJ; Clark L J Med Pract Manage; 2012; 28(2):118-20. PubMed ID: 23167027 [TBL] [Abstract][Full Text] [Related]
15. Learning to think like a user: using cognitive task analysis to meet today's health care design challenges. Militello LG Biomed Instrum Technol; 1998; 32(5):535-40. PubMed ID: 9800011 [TBL] [Abstract][Full Text] [Related]
16. Invited Commentary: Machine Learning in Causal Inference-How Do I Love Thee? Let Me Count the Ways. Balzer LB; Petersen ML Am J Epidemiol; 2021 Aug; 190(8):1483-1487. PubMed ID: 33751059 [TBL] [Abstract][Full Text] [Related]
17. Policy Implications of Artificial Intelligence and Machine Learning in Diabetes Management. Broome DT; Hilton CB; Mehta N Curr Diab Rep; 2020 Feb; 20(2):5. PubMed ID: 32008107 [TBL] [Abstract][Full Text] [Related]
18. A review of the FDA draft guidance document for software validation: guidance for industry. Keatley KL Qual Assur; 1999; 7(1):49-55. PubMed ID: 10707376 [TBL] [Abstract][Full Text] [Related]
19. Machine learning in the estimation of causal effects: targeted minimum loss-based estimation and double/debiased machine learning. Díaz I Biostatistics; 2020 Apr; 21(2):353-358. PubMed ID: 31742333 [TBL] [Abstract][Full Text] [Related]
20. New technology in electrophysiology: FDA process and perspective. Selzman KA; Fellman M; Farb A; de Del Castillo S; Zuckerman B J Interv Card Electrophysiol; 2016 Oct; 47(1):11-18. PubMed ID: 27020440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]